language_icon
EN
HI

Shelter Pharma Share price

SHELTER

32.2

2.20 (7.33%)
Last updated on 29 May, 2026 | 15:29 IST
Today's High

33.20

Today's Low

30.30

52 Week Low

26.50

52 Week High

50.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Shelter Pharma Chart

Shelter Pharma Share Key Metrics

Volume
1.23 L
Market Cap
50.51 CR
LTQ@LTP
3000@32.20
ATP
31.86
Var Margin
53.5 %
Circuit Range
24-36
Delivery %
66.67 %
Value
39.19 L
ASM/GSM
No
Market Lot
3000

Summary

Shelter Pharma share price is ₹32.2 as of 30 May, 2026. The stock Shelter Pharma intraday movement has stayed between ₹30.30 and ₹33.20, while on a 52-week basis,Shelter Pharma price 52 week high is ₹50.00 & its 52 week low is ₹26.50.
In terms of trading activity, Shelter Pharma has recorded a volume of 123000 shares, The Shelter Pharma has a market cap of ₹16836792 CR. The stock’s Average Traded Price (ATP) stands at ₹31.86, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3000 @ ₹32.20.
Shelter Pharma operates within a circuit range of ₹24.00 – ₹36.00, with a Value of ₹39.19 L. The Delivery Percentage for the day is 66.67%. Additionally, Shelter Pharma currently falls under the No framework, and trades with a market lot size of 3000.

Shelter Pharma Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

55.51

Sector P/B

3.01

Sec. Div. Yield

0.55

Shelter Pharma Resistance and Support

Pivot 30.58

Resistance

First Resistance

31.16

Second Resistance

32.33

Third Resistance

32.91

Support

First Support

29.41

Second Support

28.83

Third Support

27.66

Shelter Pharma Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2026-27
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

52.32%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

47.68%

Others

0%

Total Promoters
MAR '25
52.32%
JUN '25
52.32%
SEP '25
52.32%

Shelter Pharma Corporate Actions

DateAgenda
2026-05-28Audited Results
2025-11-10Half Yearly Results
2025-09-02A.G.M. & Final Dividend
2025-06-26Preferential Issue of shares & Others
2025-06-18To consider Fund Raising
2025-05-29Audited Results
2025-01-08Others

Shelter Pharma News

Shelter Pharma Ltd - 543963 - Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Shelter Pharma has confirmed that there was no deviation or variation in the utilization of proceeds from its Preferential Issue of Convertible Warrants. The Rs.25.31 crore raised was used for working capital requirements as approved in the July 2025 EGM, demonstrating compliance.
May 28 2026 17:24:16

Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31, 2026.

Shelter Pharma declared audited FY26 financial results, with net profit increasing 24.73% YoY to ₹902.72 lakhs and revenue growing 44.38% YoY to ₹7,313.36 lakhs. M/S. I I Lakhani & Co. were reappointed as internal auditors for FY27.
May 28 2026 16:39:07

Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May, 2026

Shelter Pharma's Board will convene on May 28, 2026, to consider and approve the audited financial results for the half year and full year ended March 31, 2026. This meeting is crucial for investor insights into the company's annual performance.
May 22 2026 17:17:02

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 International Pharmaceutical Exihibition

Shelter Pharma will participate in the iPHEX 2026 International Pharmaceutical Exhibition from September 7-9, 2026, at Bharat Mandapam. This participation aims to enhance global visibility, strengthen client relationships, and explore new export opportunities for its product portfolio.
May 18 2026 11:07:51

Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of SEBI (LODR) Regulation, 2015- New Product Launch.

Shelter Pharma launched its new healthcare product, FOLIMAN Folic Acid Tablets, on May 11, 2026. This Vitamin B-9 supplement expands the company's healthcare and nutraceutical portfolio, aiming to strengthen its market presence in international markets.
May 11 2026 11:04:08

Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 05, 2026 For Conversion Of 111000 Warrants Into 111000 Equity Shares Of Face Value Of Rs. 10/-

Shelter Pharma's Board approved the allotment of 111,000 equity shares to warrant holders at Rs. 42.25 per share, converting existing warrants. This increases the company's paid-up equity share capital by 0.66%.
May 05 2026 20:25:50

Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, May 01, 2026.

Shelter Pharma has allotted 114,000 equity shares on May 1, 2026, following the conversion of previously issued warrants by non-promoter warrant holders. This increases the company's paid-up equity share capital to Rs. 16.72 crore.
May 01 2026 12:34:10
Read More

Shelter Pharma Management

NamePosition
Mustaqim Nisarahmed SabugarManaging Director
Shakil Nisarahmed SabugarWhole Time Director
View More

Shelter Pharma FAQs

The Buying Price of Shelter Pharma share is 32.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Shelter Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Shelter Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Shelter Pharma shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Shelter Pharma shares is 0. Useful to assess the stock's value relative to its book value.

To assess Shelter Pharma’s valuation compare Sector P/E, P/B which are 55.51 & 3.01 with sector averages, along with growth rates and financial metrics.

The Market Cap of Shelter Pharma is 50.51 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Shelter Pharma share price is 50.00 & 26.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Shelter Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost